UC Berkeley SkyDeck has partnered TSMC, Cadence and SiFive to launch an accelerator track aimed at semiconductor technology developers called Chip Track.

Orphan disease drug developer PhaseBio Pharmaceuticals, which is commercialising research from Duke University, cut the price of its shares sharply pre-offering.

Cass Entrepreneurship Fund has returned to back a $3.9m funding round for Raremark, which is working on delivering precision medicine for patients suffering from rare diseases.

Qpex has raised $33m in series A funding from Stanford University Draper Fund and others after spinning out of the Medicines Company to develop drugs targeting superbugs.

Cengiz Tarhan will step down from his role as managing director of UCL Business at the end of this month, 25 years after he established tech transfer office.

Johnson & Johnson was among the investors in a $54.5m series A round for CuraSen Therapeutics, which is commercialising research from Stanford University.

Endocyte emerged out of Purdue University in 1996, completed an initial public offering in 2011 and has now agreed to an acquisition by Novartis worth $2.1bn.

A round up of all the latest news on www.globaluniversityventuring.com for our subscribers.

The Csiro Innovation Fund has invested $890,000 in RapidAim, co-founded by three Csiro researchers, to support a trial of a fruit fly monitoring system.

University of Washington’s CoMotion has formed a fintech incubator with nonprofit credit union Becu called the Becu Fintech Incubator.